Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating

Impact · against what's priced in

The court-ordered upgrade of Clover Health's PPO plan Star Rating from 3.5 to 4.5 represents a material positive catalyst for revenue growth in Payment Year 2027. This development, combined with the company's goal of full-year net income profitability in 2026, provides a tangible fundamental driver for a valuation rerating.

CLOV+0.70

No priced-in read yet